Abnormal heart rhythm: All about arrhythmias
Here at Biotricity we are trying to raise awareness about heart rhythm abnormalities, also known as arrhythmias such as atrial fibrillation. The human heart is a magnificent piece…
Biotricity update for shareholders
REDWOOD CITY, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering…
Heart attack: What it is and why does it happen?
Every 40 seconds, someone in the United States has a heart attack. Over the course of a year, approximately 790,000 Americans have a heart attack, and of these cases 580,000 are a…
What is a heart monitor?
If you have experienced any sort of heart attack symptoms, like chest pain or shortness of breath, if you’ve had a stroke, or if you suffer from suspected heart problems or…
Medical technology and IoT: mitigating security risks
Medical technology is increasingly reliant on the Internet of Things (IoT). IoT connected devices, such as medical grade wearables, constantly transmit real-time data to the Cloud…
Atrial Fibrillation (AFib): Causes, symptoms, diagnosis, treatments
Atrial fibrillation, also known as AF or AFib, is one of the most prevalent heart rhythm disorders today. According to a 2014 Journal of the American College of Cardiology study,…
Medical-Grade wearable provider Biotricity aims to increase patient adherence
REDWOOD CITY, CA – January 26, 2018 – Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric…
Medical wearables: Next generation devices will change healthcare
Medical wearable devices could transform the healthcare industry with continuous and real-time monitoring, providing quicker diagnosis and treatment of conditions. To date,…
The patient-consumer conundrum and the importance of big data
The term patient-consumer denotes a patient population that actively seeks out better care experiences, more feedback and personalization, and improved outcomes and prevention…
Biotricity announces the addition of Artificial Intelligence to its remote patient monitoring platform
REDWOOD CITY, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering…
Biotricity expands its R&D effort to capitalize on artificial intelligence
REDWOOD CITY, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering…
Biotricity announces expansion of Bioflux sales force and pilot sites
REDWOOD CITY, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering…